Intervention

Levosimendan

ClinicalTrials.gov intervention label

Clinical trials31
Recruiting0
Common conditions25
Lead sponsors shown15

Clinical trials

31 shown
Artificial Voice Analysis and Telemonitoring for Heart Failure. A Feasibility StudyNCT07664748 · 2026-06-30
NOT_YET_RECRUITING
Levosimendan in Acute Decompensated Heart FailureNCT07262723 · 2025-12-01
NOT_YET_RECRUITING
Interest of Levosimendan Preconditioning for Cardiac Surgery Under CEC in Heart Failure Patients With Impaired Ejection FractionNCT06021587 · 2023-07-01
UNKNOWN
Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal FunctionNCT07186062 · 2022-06-01
COMPLETED
Levosimendan In Ambulatory Heart Failure PatientsNCT04705337 · 2021-12-15
TERMINATED
Effect of Levosimendan on Left Ventricular Systolic Function and Heart Failure After PCI in Patients With Acute Anterior Myocardial InfarctionNCT04970238 · 2021-10-01
UNKNOWN
Levosimendan in Patients With Impaired Right Ventricular Function Undergoing Cardiac SurgeryNCT05063370 · 2021-08-18
UNKNOWN
The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve ReplacementNCT04573049 · 2020-09-01
UNKNOWN
Interest of Levosimendan in Reducing Weaning Failures of ExtraCorporeal Life Support - ECLSNCT04158674 · 2020-02-24
TERMINATED
Effect of Levosimendan or Placebo on Exercise in Advanced Chronic Heart FailureNCT03576677 · 2019-08-01
UNKNOWN
Open-Label Rollover Study of Levosimendan in PH-HFpEF PatientsNCT03624010 · 2019-04-09
COMPLETED
Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEFNCT03541603 · 2018-11-14
COMPLETED
Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent RehospitalizationsNCT03764722 · 2018-08-01
UNKNOWN
Levosimendan for Cardiac Patients Undergoing Major Abdominal Cancer SurgeriesNCT03557255 · 2017-08-01
COMPLETED
Preoperative levosimendán and Hip FractureNCT02972918 · 2014-05-01
COMPLETED
Levosimendan Versus Dobutamine for Renal Function in Heart FailureNCT02133105 · 2014-04-01
COMPLETED
Changes in Cardiac Deformation Following Physiologic Alterations and Inotropic Support.NCT02408003 · 2014-03-01
COMPLETED
Levosimendan Efficacy Assessment by Cardiopulmonary Exercise Test (CPET)NCT02261948 · 2012-09-01
COMPLETED
Levosimendan Infusion in Critically Ill Patients With Cardiogenic ShockNCT04917497 · 2011-06-30
COMPLETED
Preoperative Levosimendan and Heart FailureNCT01022983 · 2011-04-01
WITHDRAWN
ELEVATE Early LEvosimendan Vs Usual Care in Advanced Chronic hearT failurENCT01290146 · 2011-02-01
TERMINATED
Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical ChildrenNCT01301313 · 2011-02-01
TERMINATED
Intermittent Intravenous Levosimendan in Ambulatory Advanced Chronic Heart Failure PatientsNCT01536132 · 2010-04-01
COMPLETED
Long-Term Intermittent Administration of Levosimendan in Patients With Advanced Heart FailureNCT00988806 · 2009-11-01
UNKNOWN
Efficacy and Safety of Pulsed Infusions of Levosimendan in Outpatients With Advanced Heart FailureNCT01065194 · 2009-08-01
UNKNOWN
Levosimendan Administration and Outcome in Cardiac SurgeryNCT02275013 · 2006-01-01
COMPLETED
Study of Blood Concentrations and Physiologic Effects of Levosimendan Given During Heart SurgeryNCT00166127 · 2005-05-01
TERMINATED
Levosimendan Versus Dobutamine in Shock PatientsNCT00093301 · 2004-10-01
UNKNOWN
Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients.NCT00219388 · 2002-11-01
COMPLETED
Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.NCT00048425 · 2002-09-01
COMPLETED
Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart FailureNCT02973620
NO_LONGER_AVAILABLE

Common conditions

Heart Failure10Acute Decompensated Heart Failure (ADHF)2Aortic Valve Stenosis2Cardiogenic Shock2Cardiorenal Syndrome2Heart Failure With Normal Ejection Fraction2Heart Failure With Reduced Ejection Fraction2Hip Fracture2Acute Decompensated Heart Failure1Acute Heart Failure1Acute Kidney Failure1Advanced Chronic Heart Failure1Advanced Heart Failure1Cardiac Event1Cardiac Surgery1Cardiorenal Syndrome (CRS)1Chronic Stable Heart Failure1Effect of Drug1Heart Decompensation1Heart Failure New York Heart Association Class III1Heart Failure New York Heart Association Class IV1Heart Failure, Congestive1Heart Failure, Diastolic1Heart Failure, Right Sided1Heart Failure, Systolic1

Trial status mix

COMPLETED13
UNKNOWN9
TERMINATED5
NOT_YET_RECRUITING2
NO_LONGER_AVAILABLE1
WITHDRAWN1

Phase mix

PHASE411
PHASE38
PHASE27
NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.